Biomarin Pharmaceutical Inc at JPMorgan NAPA Valley Forum (Virtual) Transcript
All right. Hi, everybody. Good afternoon, or good morning, and thanks for joining the next session in our 10th Annual second time virtual JPMorgan Biotech Napa Valley Forum. It's my pleasure now to host a discussion with BioMarin Pharmaceutical. As you can see here, we have J.J. Bienaime, the CEO; Hank Fuchs, President of Worldwide R&D; as well as Brian Mueller, the CFO. So thank you all very much for joining us. We, of course, wish we were doing this in person at the Solage, but this will have to do for now, and look forward to being in person next year.
Remind our listeners that you do have the ability to contribute to this discussion by using that little blue button in the portal. And you can send me questions that we'll work in throughout this conversation. Before we get started, though, let me just turn things over to J.J. for a little quick intro, and then we'll move on to the Q&A. So J.J.?
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
